Keen Vision Acquisition Corporation shares rise 3.48% premarket after NeOnc Technologies' strategic acquisition of AI, 3D bioprinting, and quantum modeling technologies.

Keen Vision Acquisition Corporation rose 3.48% in premarket trading. The company's stock price increase may be attributed to the recent acquisition of an intellectual property portfolio by NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI), which includes U.S. Patent No. 11,788,057 B2. This acquisition allows NeOnc to create highly sophisticated, patient-derived 3D brain tumor models, applying proprietary AI and quantum modeling algorithms to these realistic biological environments. This move significantly fortifies NeOnc’s drug discovery engine and helps accelerate its mission to develop therapies for complex neurological cancers.